Mitchison DA - Search Results

1

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

Hu Y, Coates AR, Mitchison DA. Hu Y, et al. Among authors: mitchison da. Antimicrob Agents Chemother. 2003 Feb;47(2):653-7. doi: 10.1128/AAC.47.2.653-657.2003. Antimicrob Agents Chemother. 2003. PMID: 12543673 Free PMC article.

2

Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs.

Mitchison DA, Coates AR. Mitchison DA, et al. Curr Pharm Des. 2004;10(26):3285-95. doi: 10.2174/1381612043383269. Curr Pharm Des. 2004. PMID: 15544516 Review.

3

Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock.

Hu YM, Butcher PD, Sole K, Mitchison DA, Coates AR. Hu YM, et al. Among authors: mitchison da. FEMS Microbiol Lett. 1998 Jan 1;158(1):139-45. doi: 10.1111/j.1574-6968.1998.tb12813.x. FEMS Microbiol Lett. 1998. PMID: 9453166

4

Metronidazole has no antibacterial effect in Cornell model murine tuberculosis.

Dhillon J, Allen BW, Hu YM, Coates AR, Mitchison DA. Dhillon J, et al. Among authors: mitchison da. Int J Tuberc Lung Dis. 1998 Sep;2(9):736-42. Int J Tuberc Lung Dis. 1998. PMID: 9755928

5

Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide.

Hu Y, Mangan JA, Dhillon J, Sole KM, Mitchison DA, Butcher PD, Coates AR. Hu Y, et al. Among authors: mitchison da. J Bacteriol. 2000 Nov;182(22):6358-65. doi: 10.1128/JB.182.22.6358-6365.2000. J Bacteriol. 2000. PMID: 11053379 Free PMC article.

6

Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.

Hu Y, Coates AR, Mitchison DA. Hu Y, et al. Among authors: mitchison da. Int J Tuberc Lung Dis. 2006 Mar;10(3):317-22. Int J Tuberc Lung Dis. 2006. PMID: 16562713

7

Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis.

Hu Y, Coates AR, Mitchison DA. Hu Y, et al. Among authors: mitchison da. Int J Tuberc Lung Dis. 2008 Jan;12(1):69-73. Int J Tuberc Lung Dis. 2008. PMID: 18173880

8

HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic target.

Hu Y, Liu A, Menendez MC, Garcia MJ, Oravcova K, Gillespie SH, Davies GR, Mitchison DA, Coates AR. Hu Y, et al. Among authors: mitchison da. Tuberculosis (Edinb). 2015 Jan;95(1):31-6. doi: 10.1016/j.tube.2014.11.002. Epub 2014 Nov 20. Tuberculosis (Edinb). 2015. PMID: 25481272

9

Contradictory results with high-dosage rifamycin in mice and humans.

Coates AR, Hu Y, Jindani A, Mitchison DA. Coates AR, et al. Among authors: mitchison da. Antimicrob Agents Chemother. 2013 Feb;57(2):1103. doi: 10.1128/AAC.01705-12. Antimicrob Agents Chemother. 2013. PMID: 23341429 Free PMC article. No abstract available.

10

High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo.

Hu Y, Liu A, Ortega-Muro F, Alameda-Martin L, Mitchison D, Coates A. Hu Y, et al. Front Microbiol. 2015 Jun 23;6:641. doi: 10.3389/fmicb.2015.00641. eCollection 2015. Front Microbiol. 2015. PMID: 26157437 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters